The role, costs and value for money of external consultancies in the health sector: A study of New Zealand's District Health Boards. Issue 4 (April 2017)

• Record Type: Journal Article
• Authors: Penno, Erin; Gauld, Robin
• Is Part Of: Health policy. Volume 121:Issue 4(2017)
• Page Start: 458
• Page End: 467
• Publication Date: 2017-04
• Subjects: Consultancies -- Consultants -- New Zealand health system -- Value for money; Medical education -- Periodicals; Medical policy -- Periodicals; Delivery of Health Care -- Periodicals; Education, Medical -- Periodicals; Health Education -- Periodicals; Health Planning -- Periodicals; Public Policy -- Periodicals; Enseignement médical -- Périodiques; Politique sanitaire -- Périodiques; Medical education; Medical policy; Periodicals; Electronic journals; Electronic journals; 362.1
• DOI: 10.1016/j.healthpol.2017.02.005
• Languages: English
• ISSNs: 0168-8510

Abstract

Highlights: Internationally, spending on external consultants within the health sector is increasing rapidly. Spending on external consultants by New Zealand's District Health Boards is substantial. Many were unable to easily identify the extent or purpose of consultancy activity. Few had policies in place on engaging consultants or ensuring value for money. There is a need for greater accountability for expenditure and value for money. Abstract: Public spending on external consultancies, particularly within the health sector, is highly controversial in many countries. Yet, despite the apparently large sums of money involved, there is little international analysis surrounding the scope of activities of consultants, meaning there is little understanding of how much is spent, for what purpose and with what result. This paper examines spending on external consultancies in each of New Zealand's 20 District Health Boards (DHB). Using evidence obtained from DHBs, it provides an insight into the cost and activities of consultants within the New Zealand health sector, the policies behind their engagement and the processes in place to ensure value for money. It finds that DHB spending on external consultants is substantial, at $NZ10–60 million annually. However, few DHBs had policies governing when consultants should be engaged and many were unable to easily identify the extent or purpose of consultancies within their organisation, making it difficult to derive an accurate picture of consultant activity throughout the DHB sector. Policies surrounding value for money were uncommon and, where present, were rarely applied. Given the large sums being spent by New Zealand's DHBs, and assuming expenditure is similar in other health systems, our findings point to the need for greater accountability for expenditure and better evidence of value for money of consultancies within publicly funded health systems.